(Total Views: 454)
Posted On: 10/28/2021 10:34:41 PM
Post# of 145254
I'm not saying that's true. I'm saying that's something a 3-arm trial could address. We have at least the anecdotes from Dr. D's case as a hint that might be true. And forgive me if I misquote Ohm, but I believe he/she said that checkpoint inhibitors method of action is something Leronlimab would accomplish by itself, rendering them superfluous and thus avoiding the checkpoint inhibitors' side effects, which are not negligible.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)